Effects of preconceptional paternal drug exposure on birth outcomes: Cohort study of 340000 pregnancies using Norwegian population-based databases

British Journal of Clinical Pharmacology

Volumn 75, Issue 4, 2013, Pages 1134-1141

  Engeland, Anders ^a,b   Bjørge, Tone ^a,b   Daltveit, Anne Kjersti ^a,b   Skurtveit, Svetlana ^a,c   Vangen, Siri ^a,d   Vollset, Stein Emil ^a,b   Furu, Kari ^a,e  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Birth defects; Cohort; Drug prescriptions; Population based registries

Indexed keywords

ANDROGEN; AZATHIOPRINE; CIMETIDINE; DAUNORUBICIN; DIAZEPAM; ERGOTAMINE; ETRETIN; FUROSEMIDE; INDOMETACIN; ISOTRETINOIN; LITHIUM; METHOTREXATE; MORPHINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; SALAZOSULFAPYRIDINE; SPIRONOLACTONE; VALPROIC ACID;

ARTICLE; BIRTH DEFECT; CARDIOVASCULAR MALFORMATION; CHROMOSOME ABERRATION; COHORT ANALYSIS; DOWN SYNDROME; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HYDRONEPHROSIS; INTRAUTERINE GROWTH RETARDATION; KIDNEY AGENESIS; KIDNEY DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NORWAY; PERINATAL MORTALITY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY TRACT MALFORMATION; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; COHORT STUDIES; CONGENITAL ABNORMALITIES; DATABASES, FACTUAL; FATHERS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; MIDDLE AGED; NORWAY; PERINATAL MORTALITY; PREMATURE BIRTH; PRESCRIPTION DRUGS;

EID: 84875074897     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04426.x     Document Type: Article

References (22)

1. De SM, Cesari E, Cavaliere A, Ligato MS, Nobili E, Visconti D, Caruso A. Paternal exposure and counselling: experience of a Teratology Information Service. Reprod Toxicol 2008; 26: 42-46.
2. Delbes G, Hales BF, Robaire B. Toxicants and human sperm chromatin integrity. Mol Hum Reprod 2010; 16: 14-22.
3. Nguyen RH, Wilcox AJ, Moen BE, McConnaughey DR, Lie RT. Parent's occupation and isolated orofacial clefts in Norway: a population-based case-control study. Ann Epidemiol 2007; 17: 763-771.
4. Winther JF, Boice JD Jr, Frederiksen K, Bautz A, Mulvihill JJ, Stovall M, Olsen JH. Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a population-based cohort study. Clin Genet 2009; 75: 50-56.
5. Begg EJ. Prescribing in pregnancy and lactation. Br J Clin Pharmacol 2008; 65: 627-628.
6. Schirm E, Pedersen L, Tobi H, Nielsen GL, Sørensen HT, de Jong-van den Berg LT. Drug use among fathers around time of conception: two register based surveys from Denmark and the Netherlands. Pharmacoepidemiol Drug Saf 2004; 13: 609-613.
7. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106000 pregnancies in Norway 2004-06. Br J Clin Pharmacol 2008; 69: 653-660.
8. Lee CY, Jin C, Mata AM, Tanaka T, Einarson A, Koren G. A pilot study of paternal drug exposure: the Motherisk experience. Reprod Toxicol 2010; 29: 353-360.
9. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 2008; 18: 129-136. Available at http://www.ntnu.no/ojs/index.php/norepid/article/view/23 (last accessed 5 September 2012).
10. WHO Collaborating Centre for Drug Statistics Methodology. WHO collaborating centre for drug statistics methodology. 2010. Available at http://www.whocc.no/ (last accessed 5 September 2012).
11. Irgens LM. The Medical Birth Registry of Norway. epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-439.
12. Skjærven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 2000; 79: 440-449.
13. Nguyen RH, Wilcox AJ. Terms in reproductive and perinatal epidemiology: 2. Perinatal terms. J Epidemiol Community Health 2005; 59: 1019-1021.
14. Crijns I, Bos J, Knol M, Straus S, de Jong-van den Berg L. Paternal drug use: before and during pregnancy. Expert Opin Drug Saf 2012; 11: 513-518.
15. Shah PS. Paternal factors and low birthweight, preterm, and small for gestational age births: a systematic review. Am J Obstet Gynecol 2010; 202: 103-123.
16. Eidem I, Stene LC, Henriksen T, Hanssen KF, Vangen S, Vollset SE, Joner G. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999-2004. Acta Obstet Gynecol Scand 2010; 89: 1403-1411.
17. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008; 81: 1-13.
18. Misra DP, Caldwell C, Young AA Jr, Abelson S. Do fathers matter? Paternal contributions to birth outcomes and racial disparities. Am J Obstet Gynecol 2010; 202: 99-100.
19. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307: 846-848.
20. French AE, Koren G. Effect of methotrexate on male fertility. Can Fam Physician 2003; 49: 577-578.
21. Viktil K, Engeland A, Furu K. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41: 196-201.
22. Marinucci L, Balloni S, Carinci F, Locci P, Pezzetti F, Bodo M. Diazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrix. Expert Opin Drug Saf 2011; 10: 23-33.